Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Prepaid Assets (2022 - 2025)

Corvus Pharmaceuticals has reported Prepaid Assets over the past 4 years, most recently at $35000.0 for Q3 2025.

  • Quarterly results put Prepaid Assets at $35000.0 for Q3 2025, down 97.08% from a year ago — trailing twelve months through Sep 2025 was $35000.0 (down 97.08% YoY), and the annual figure for FY2024 was $308000.0, up 106.71%.
  • Prepaid Assets for Q3 2025 was $35000.0 at Corvus Pharmaceuticals, down from $37000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for CRVS hit a ceiling of $1.2 million in Q3 2024 and a floor of $35000.0 in Q3 2025.
  • Median Prepaid Assets over the past 4 years was $149000.0 (2023), compared with a mean of $419400.0.
  • Biggest five-year swings in Prepaid Assets: soared 618.38% in 2024 and later crashed 97.08% in 2025.
  • Corvus Pharmaceuticals' Prepaid Assets stood at $102000.0 in 2022, then surged by 46.08% to $149000.0 in 2023, then soared by 106.71% to $308000.0 in 2024, then tumbled by 88.64% to $35000.0 in 2025.
  • The last three reported values for Prepaid Assets were $35000.0 (Q3 2025), $37000.0 (Q2 2025), and $87000.0 (Q1 2025) per Business Quant data.